Skip to main content
. 2023 Jul 28;17:1186520. doi: 10.3389/fnins.2023.1186520

Figure 3.

Figure 3

Oral pioglitazone (PIO) enhanced SDHA and COX-I expression levels in multiple brain regions of 6-OHDA-injected and control rats. Representative Western blots (A,C,E,G) and quantification (B,D,F,H) of SDHA and COX-I protein expression levels in the striatum (A,B), prefrontal cortex (C,D), hippocampus (E,F) and cerebellum (G,H) of CN, 6-OHDA, CN + PIO and 6-OHDA + PIO groups. β-actin was used as the gel loading control. Results are presented as mean ± SEM of n = 8 rats per group. *p < 0.05 vs. CN group and &p < 0.05 vs. 6-OHDA group by one-way ANOVA with post hoc Bonferroni tests.